Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 1

1(25.0%)

4Total

N/A(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05549453Not ApplicableCompleted

Use of Nexstim SNBT System

Role: lead

NCT03010462Not ApplicableCompleted

Electric Field Navigated 1hz Rtms for Post-stroke Motor Recovery Trial

Role: lead

NCT02089464Not ApplicableCompleted

Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial

Role: lead

NCT01049802Phase 1Completed

Contrastim Stroke Trial

Role: collaborator

NCT01005394Terminated

Navigated Transcranial Magnetic Stimulation in Monitoring Stroke Recovery

Role: lead

NCT01018290Terminated

Navigated Transcranial Magnetic Stimulation in Tumor Surgery

Role: lead

All 6 trials loaded